| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ceranib-2 | CTRPv2 | pan-cancer | AAC | -0.075 | 0.03 |
| mRNA | WZ3105 | GDSC1000 | pan-cancer | AAC | -0.065 | 0.03 |
| mRNA | BRD-K70511574 | CTRPv2 | pan-cancer | AAC | -0.073 | 0.03 |
| mRNA | Doxorubicin | CTRPv2 | pan-cancer | AAC | -0.067 | 0.03 |
| mRNA | NVP-ADW742 | CTRPv2 | pan-cancer | AAC | -0.079 | 0.03 |
| mRNA | ML162 | CTRPv2 | pan-cancer | AAC | 0.076 | 0.03 |
| mRNA | BMS-754807 | CTRPv2 | pan-cancer | AAC | -0.078 | 0.03 |
| mRNA | tubastatin A | GDSC1000 | pan-cancer | AAC | -0.066 | 0.03 |
| mRNA | SB-431542 | CTRPv2 | pan-cancer | AAC | -0.084 | 0.03 |
| mRNA | alisertib:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.078 | 0.03 |